trade name Lipitor, ends today (November 30) with the expiration of the patent that has brought the company over $100 billion since the drug was introduced in 1997. While the introduction of generic ...

Pfizer will seek to hold onto sales of its cholesterol fighter Lipitor, even after it loses U.S. patent protection at the end of this month, by selling the pills at generic prices directly to ...

The most prescribed drug in America is atorvastatin, which is used to treat high cholesterol and can help prevent heart attacks and strokes.

Pfizer Inc (NYSE:PFE) has agreed to pay $93 million to settle an antitrust lawsuit related to its cholesterol drug Lipitor.

With respect to advertising, Pfizer (USA) markets atorvastatin as preventing heart attacks. The advertising does not disclose that the drug was associated with increased risk to women, not ...

The threat of losing market exclusivity for the blockbuster antiplatelet drug Plavix (clopidrogel), has suddenly turned into a reality for its co-marketers Bristol-Myers Squibb (BMS) and Sanofi ...

The central repository of the drug and medication centre helps to navigate to different sections. Medindia's platform provides carefully curated details on generics, brand names, side-effects ...

Although a decision in Germany in October invalidated the patents, Pfizer is set to appeal and Ranbaxy does not yet have marketing approval for the generic version in this country. With Lipitor ...